Zohaib Ahmed

In the dim-lit corridors of the 2018 Farm Bill, a single clause slipped through like a fox in the henhouse. Section 10113 redefined hemp as any cannabis plant with 0.3% or less delta-9 THC by dry weight, effectively removing it from the Controlled Substances Act. What Congress intended as agricultural relief for Kentucky farmers became […]

In the ever-evolving landscape of natural health, where ancient plants meet modern science, two unassuming compounds are stealing the spotlight: THCa and CBDa. These raw cannabinoids, the untouched precursors to their more famous cousins THC and CBD, are not just chemical curiosities—they’re catalysts for a quieter, clearer path to well-being. Imagine sipping a vibrant green

The year 2025 marks a pivotal moment for industrial hemp, a crop once stigmatized but now thriving across 1.2 million acres in the United States alone, according to the USDA’s latest National Hemp Report. Global cultivation has surged 300% since 2018, fueled by the 2018 Farm Bill’s legalization of hemp containing less than 0.3% THC.

The global hemp cannabinoid market hit $5.8 billion in 2024 and is projected to reach $19.2 billion by 2030, growing at a compound annual rate of 22.1 percent, according to Grand View Research. This surge isn’t driven by hype alone; it’s fueled by science that finally solves an old problem—how to get cannabinoids like CBD

In the hazy dawn of the cannabis revolution, a peculiar underdog emerged from the shadows of the 2018 Farm Bill: intoxicating hemp cannabinoids. These compounds, derived from industrial hemp plants boasting less than 0.3% delta-9 THC, promised a legal high without the federal felony. Delta-8 THC, THCA, HHC, and their synthetic cousins flooded markets, turning

In the kaleidoscopic world of wellness and recreation, 2025 marks the year hemp-derived THC doesn’t just knock on the door—it kicks it wide open. Once a whisper in the shadows of cannabis culture, this federally legal cousin to marijuana has exploded into a $3.5 billion juggernaut, up from a modest $200 million in 2020. Projections

In the ever-evolving world of cannabis, the spotlight has long been on THC and CBD, the power duo driving the industry’s multibillion-dollar surge. But as we step into 2025, a new chapter unfolds with the ascent of minor cannabinoids—those lesser-known compounds that pack potent therapeutic punches without the fanfare. THCa and CBG, in particular, are

In the ever-evolving world of cannabis, a quiet revolution is taking root—one that’s as green as the plants themselves. As we hit October 2025, the industry is pivoting toward sustainability, driven by consumer demand, regulatory pressures, and the stark reality of climate change. Gone are the days when cannabis farming was synonymous with energy-guzzling indoor

As we step into 2025, the cannabis world is buzzing with innovation, where breeders push boundaries to create strains that tantalize the senses and elevate experiences. Exotic THC strains are at the forefront, blending rare genetics with potent effects and unforgettable flavors. These aren’t your everyday buds; they’re crafted for connoisseurs seeking something extraordinary. From

Imagine stepping into a dispensary where the air hums with invisible symphonies—citrus zests mingling with pine whispers, earthy undertones clashing against floral sighs. This isn’t mere ambiance; it’s the frontline of a sensory uprising in the cannabis world. Terpene-driven THC strains are rewriting the rules, transforming a once-marginalized plant into a gourmet experience that rivals